Pharmaco-virological algorithm to target risk of drug resistance among a population of HIV-infected key populations in Togo.
Valentine Marie FerréAlexandra M Bitty-AndersonGilles PeytavinMinh P LêClaver A DagnraRomain CoppéeFifonsi A Gbeasor-KomlanviDiane DescampsCharlotte CharpentierDidier K EkoueviPublished in: Journal of medical virology (2023)
We reported first data about HIV care cascade among key populations in Togo, highlighting they are tested for HIV but linkage to care remains a concern. Furthermore, 70-80% of ARV-treated participants experienced virological success. In limited resources settings, where genotyping tests are beyond reach, PK-VA might be an easiest solution to sort out patients needing ARV adaptation due to resistance. This article is protected by copyright. All rights reserved.
Keyphrases
- hiv infected
- antiretroviral therapy
- human immunodeficiency virus
- end stage renal disease
- hiv positive
- hiv infected patients
- newly diagnosed
- hiv aids
- chronic kidney disease
- genome wide
- ejection fraction
- healthcare
- hiv testing
- machine learning
- genetic diversity
- palliative care
- gene expression
- patient reported outcomes
- quality improvement
- electronic health record
- men who have sex with men
- dna methylation
- pain management
- artificial intelligence